Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Caffeine + chromium picolinate is a combination dietary supplement containing two active ingredients. Caffeine is a central nervous system stimulant that increases alertness, reduces fatigue, and can enhance metabolic rate by antagonizing adenosine receptors in the brain. Chromium picolinate is a supplemental form of the essential trace mineral chromium, which plays a role in carbohydrate and lipid metabolism by enhancing insulin action and improving glucose utilization[5][8]. This combination has been marketed primarily for weight management or metabolic support. While caffeine increases energy expenditure and may promote thermogenesis, chromium picolinate may help regulate blood sugar levels; however, evidence for significant synergistic effects on weight loss or metabolism remains limited[2][3]. The product is typically used as an over-the-counter dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on caffeine + chromium picolinate.